PR0535342 - Laserfiche WebLink

Home Browse Search

LFR Levine-Fricke ingestion. Other effects include skin changes, irritation of the throat, increased risk of cancer of the liver, bladder, kidney, and lung. • The OSHA PEL is listed as 0.01 mg/m' for inorganic forms of arsenic and 0.5 mg/m' for organic forms. • The Cal/OSHA PEL is listed as 0.01 mg/m' for inorganic forms of arsenic and 0.2 mg/m' for organic forms. • The TLV is listed as 0.01 mg/m' for arsenic and inorganic arsenic compounds. WARNING: This chemical is known to the State of California to cause cancer. WARNING: This chemical is known to the State of California to cause birth defects or other reproductive harm. BERYLLIUM Beryllium is a confirmed carcinogen with experimental carcinogenic, neoplastigenic, and teratogenic data. Human systemic effects by inhalation include lung fibrosis, dyspnea, and weight loss. • The OSHA PEL is listed as 0.002 mg/m'. • The Cal/OSHA PEL is listed as 0.002 mg/m'. • The TLV is listed as (a value of 0.0002 mg/m' is proposed). WARNING: This chemical is known to the State of California to cause cancer. CHROMIUM Chromium is a greenish-blue, odorless solid. Chromic acid and its salts have a corrosive action on the skin and mucous membranes. The lesions are confined to the exposed parts, affecting chiefly the skin of the hands and forearms and the mucous membranes of the nasal septum. Chromate salts are human and experimental carcinogens of the lungs, nasal cavity, and paranasal sinus, and are also experimental carcinogens of the stomach and larynx. Hexavalent compounds are more toxic than trivalent. Exposure to chromium has been associated with lung changes in workers exposed to chromium alloys. Chromium dust exposure may cause minor lung changes. • The OSHA PEL is listed as 0.1 mg/m' for chromic acid (Cr[Vl]), 0.5 mg/m' for Cr(III) compounds, and 1.0 mg/m' for chromium as a metal. • The Cal/OSHA PEL is listed as 0.01 mg/m' for insoluble Cr(VI) compounds, and 0.5 mg/m' for other forms. Page A-2 HSP-TncyTircFim-GWSarM1ing:jab